Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies

Blood - United States
doi 10.1182/blood-2018-99-118456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-Cxcr4 Antibody Induces Apoptosis of Hematologic Malignancies

PLoS ONE
Multidisciplinary
2016English

Next Generation XPO1 Inhibitor Shows Improved Efficacy and in Vivo Tolerability in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

CD26 Is a Potential Therapeutic Target by Humanized Monoclonal Antibody for the Treatment of Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2018English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Improving the Detection of Patients With Inherited Predispositions to Hematologic Malignancies Using Next-Generation Sequencing-Based Leukemia Prognostication Panels

Cancer
Cancer ResearchOncology
2018English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy